Resources
157 Results (showing 11 - 20)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 4/26/2021 (updated 4/10/2024)
A Protocol Using Empirically Supported Behavioral Treatments for People with Psychoactive Stimulant Use Disorders
Posted 4/5/2024
This study assessed the associations between insurance status and 6-month retention of patients with opioid use disorder on telehealth platforms. Patients whose insurance paid for their care were most likely to still be receiving buprenorphine 6 months after starting treatment. Uninsured patients who paid cash were more likely to be in treatment at 6 months than people with insurance that did not cover their care. Findings showed an association between in-network insurance benefits and retention, which may affect the opioid crisis.
Posted 4/21/2021 (updated 4/5/2024)
This News Brief describes the need for harm reduction and treatment services in rural areas for people who use psychostimulants and how those services can be provided by the opioid treatment program
Posted 3/25/2021 (updated 4/5/2024)
Care Coordination: Navigating Individuals With OUD Through a Treatment and Recovery Continuum
Presenters from the Western Region will describe two innovative care coordination strategies and models from the RCORP/Rural Health Opioid Program grantee perspective.
Posted 3/25/2021 (updated 4/5/2024)
Stimulants 2021: An Update—Clinical Issues and Treatments
The presenter will review considerations in engaging and treating individuals with stimulant use disorders and present evidence-based treatment strategies relevant to rural communities addressing this growing problem.
Posted 3/25/2021 (updated 4/5/2024)
Integrating Health Promotion for People Who Inject Drugs (PWID) Into Opioid Use Disorder (OUD) Services
The workshop will present strategies to integrate HIV, hepatitis, and sexual health concerns into services for PWID. The session will focus on communication skills, assessment techniques, and building motivation among PWID to make healthier choices. The presenter will look at programmatic and clinical-level integration strategies and offer participants an opportunity to assess current service delivery models and develop a plan to enhance care.
Posted 3/25/2021 (updated 4/5/2024)
Federal Resources: A Virtual Tour
Presenters will review resources available to rural grantees through their respective organizations.
Christina Mead, PharmD, Regional Pharmacy Consultant, U.S. Public Health Service, U.S. Department of Health and Human Services/HRSA/Office of Regional Operations
Kristin Martinsen, MPA, Director, Hospital State Division, FORHP, HRSA
Betty-Ann Bryce, JD, MPA, Special Advisor for Rural Affairs, Office of National Drug Control Policy
Humberto Carvalho, MPH, Grants Project Manager, Substance Abuse and Mental Health Services Administration
Posted 3/23/2021 (updated 4/5/2024)
This webinar provided an overview of the statute and regulations of 42 CFR, Part 2, the federal regulations for confidentiality of substance use records. It provided a brief history of the statute and its original purpose, and the three major revisions to the regulations. It covered the changes to the statute that were made as part of the CARES Act last year and its impact on providers. It covered the issue of applicability of the regulations as they have evolved over the three major revisions.
Posted 3/2/2021 (updated 4/4/2024)
In light of the accelerating and rapidly evolving overdose crisis in the United States (US), new strategies are needed to address the epidemic and to efficiently engage and retain individuals in care for opioid use disorder (OUD). Moreover, there is an increasing need for novel approaches to using health data to identify gaps in the cascade of care for persons with OUD.
Posted 2/24/2021 (updated 4/4/2024)
This webinar provided new information on the risks and clinical challenges presented by individuals who use psychostimulants (cocaine, methamphetamine and prescription stimulants). A review of the clinical strategies that are important in working with this population were presented, including psychosocial and medication treatments for those with stimulant use disorder. Presented by Richard Rawson, Ph.D.